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Abstract 
Background: Limited studies have examined the diagnostic performance of body mass index 
(BMI), waist circumference (WC) or waist to height ratio (WHtR) for identifying 
cardiometabolic risk (increased clustered glucose, triglycerides, mean arterial pressure and 
inv-HDL-cholesterol) in pre-adolescent youth. 
Aim: To compare the utility of BMI, WC and WHtR as predictors of cardiometabolic risk 
(CMR) in Scottish pre-adolescent children.  
Subjects and Methods: A cross-sectional analysis of 223 Scottish children (55.2% boys, mean 
age 8.4 years) was undertaken. BMI, WC and WHtR were used as exposure variables within 
multivariate logistic regression analysis and ROC analysis to examine the utility of these 
anthropometrical indices in identifying those at cardiometabolic risk.  
Results: Individuals with an elevated WHtR, WC and BMI were 3.51 (95% CI: 1.71-7.23; P 
< 0.001); 2.34 (95% CI: 1.35-4.06; P= 0.002) and 2.59 (95% CI: 1.42-4.73; P=0.002) times 
more likely to be at cardiometabolic risk. The areas under the curves [AUC] to identify 
children with cardiometabolic risk were significant and similar among anthropometric indices 
(AUC’s = 0.60 - 0.65). When stratified by BMI, both WC and WHtR demonstrated a fair to 
good ability for identifying those at cardiometabolic risk (AUC = 0.75 - 0.81). 
Conclusions: Findings suggest that the combination of BMI with either WC or WHtR may 
provide an added benefit in the assessment of cardiometabolic risk amongst pre-adolescents. 
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Introduction 
Given the well-established evidence linking adverse weight status in childhood as being 
predictive of cardiometabolic complications in adulthood (Morrison et al., 2008, Juonala et 
al., 2011), some have described the increasing prevalence of obesity as a global pandemic 
(Swinburn et al., 2011). Childhood obesity is commonly defined by body mass index (BMI, 
kg/m2) due to its simplicity of measurement and available normative growth charts for age 
and sex that provide recommendations for practitioners to define childhood overweight and 
obesity. When using these growth charts it is assumed that the BMI thresholds are predictive 
of cardiometabolic risk but little diagnostic evidence exists. Moreover, excess visceral 
adiposity appears to be a stronger predictor for cardiometabolic dysfunction than total 
adiposity in adults (Alberti et al., 2009)  leading some to question whether practitioners 
should still be using BMI to identify children at risk of obesity-related disorders.    
 
The measurement of waist circumference (WC) can be used as a simple and inexpensive 
proxy measure of abdominal obesity and cardiometabolic dysfunction (Alberti et al., 2009) 
but whether BMI is a better indicator than WC for cardiometabolic dysfunction in youth is 
unclear. Whilst some suggest that WC may be a better indicator than BMI for identifying 
children at risk of cardiometabolic dysfunction (Alberti et al., 2009, Savva et al., 2000), 
others suggest that both measures have similar predictive abilities (Lawlor et al., 2010, 
Falaschetti et al., 2010). It has been proposed that a waist-height ratio (WHtR) ≥ 0.5 is a valid 
predictor of cardiometabolic risk irrespective of age, sex or ethnicity which may be superior 
than BMI to identify cardiometabolic risk in youth (Kahn et al., 2005, Adegboye et al., 2010, 
Freedman et al., 2007). Nonetheless, the paucity of evidence which has examined the 
predictive utility of these three adiposity indicators as predictors of cardiometabolic risk is 
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sparse and inconsistent. Whereas some authors suggest that WHtR is a better predictor of 
cardiometabolic risk than both BMI and WC (Kahn et al., 2005, Savva et al., 2000), others 
report no differences in their predictive abilities (Sardinha et al., 2016, Graves et al., 2014, 
Kahn et al., 2014). Moreover, previous studies have tended to focus on North American 
cohorts resulting in a paucity of evidence relating to cohorts living in different cultural 
settings.  
 
The aim of this study was to examine the predictive utility of BMI-z and WC-z (determined 
using age and sex specific UK national reference values (Cole et al., 1995, McCarthy et al., 
2001) as well as WHtR to identify individuals at risk of clustering of cardiometabolic risk. 
 
Methods 
In this cross-sectional study, 330 participants volunteered to participate. Participants were 
excluded if they did not have valid data for all outcome variables resulting in 223 children 
(55.2% boys, mean age 8.4 years, range 5.4 to 12.3 years) being included within the analysis. 
The proposed methodology for this study was outlined in detail to participants and given 
ethical approval by the University of the West of Scotland ethical committee.  
 
Anthropometric Indicators:  
Height was measured barefoot to the nearest 0.1cm using a portable stadiometer (Seca 
Stadiometer, Seca Ltd, Birmingham, UK). Weight was measured barefoot with light clothing 
to the nearest 0.1kg on electronic scales (Seca Digital Scales, Seca Ltd, Birmingham, UK). 
Waist circumference was obtained using inelastic gulick tape with BMI calculated as the 
weight in kilograms divided by the square of height in metres. Waist circumference (cm) was 
measured in a standing position midway between the lower rib and the anterior superior iliac 
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spine following a normal expiration (Ledoux et al., 1997) with WHtR calculated by dividing 
WC (cm) by height (cm). In order to facilitate the analysis of results between different 
genders and ages, values of each variable was standardized using the following procedures. 
From measured height and weight, participants were classified as obese/overweight, or a 
healthy weight using BMI-z scores relative to the UK 1990 BMI population reference data 
(Cole et al., 1995). Using software provided by the Child Growth Foundation (Pan and Cole, 
2010) the following definitions were applied for healthy weight (BMI z-score <1.04, below 
the 85th percentile) and overweight / obese (BMI z-score ≥1.04, above the 85th percentile) 
individuals.  Waist circumference-z scores were calculated relative to the UK 1988 reference 
data  (McCarthy et al., 2001) using software provided by the Child Growth Foundation (Pan 
and Cole, 2010) with a high WC defined as  ≥ the 85th percentile (z-score ≥1.04). WHtR 
values ≥ 0.5 were considered elevated. 
 
Blood Pressure: 
Blood pressure (mmHg) was measured in an upright seated position using an automated 
monitor (Omron M10-IT Blood Pressure Monitor HEM-7080IT-E, Omron Healthcare UK 
Ltd, Milton Keynes, UK) after participants sat quietly for 10 minutes.  Blood pressure was 
converted to standardized z-scores using software provided by the Child Growth Foundation 
(Pan and Cole, 2010) with values greater than the 91st percentile considered elevated as 
recommended (Jackson et al., 2007) . 
 
Blood Measures: 
Capillary blood samples were obtained from the finger and analysed using a point-of-care 
analyser. Participants were required to fast at least 12 hours prior to sampling with breakfast 
provided immediately after sampling. Verbal confirmation of fasting was confirmed prior to 
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sampling. Blood samples obtained were transferred into a cassette sample well and placed in 
the drawer of the analyser to provide a measure of triglycerides (TRGS), high-density-
lipoprotein cholesterol (HDL-c) and glucose (GLU). The Cholestex LDX® analyser 
(Cholestech Corporation, Hayward, California) has demonstrated good clinical utility with 
core laboratory values (r = 0.77-0.91)  and meets the criteria set by the lipid standardization 
panel (Dale et al., 2008).   
 
Cardiometabolic Risk Factors: 
In children less than 11 years of age abnormal levels of triglycerides, HDL-cholesterol and 
glucose were determined based on age and gender specific monitoring thresholds proposed 
from the IDEFICS study (Ahrens et al., 2014). For children ≥11 years of age, reference 
values from the National Cholesterol Education Programmes (NCEP) Pediatric Report was 
used to identify abnormal triglyceride concentrations as ≥1.24mmol/L and low HDL-c levels 
≤1.03mmol/L (National Cholesterol Education Program, 1992) whereas impaired fasting 
glucose was defined as ≥5.6 mmol/L as recommended by the International Diabetes 
Federation (Zimmet et al., 2007). An age and sex adjusted cardiometabolic risk score 
(composite z-score) was calculated for each participant using the sum of the z-scores for the 
following variables; glucose, triglycerides, mean arterial pressure and inv-HDL-cholesterol. 
The cardiometabolic risk score was dichotomized at the cut-off value mean + 1SD, to identify 
those participants with elevated cardiometabolic risk as described  previously (Sardinha et al., 
2016). 
 
Statistical Analysis: 
All data was analysed using IBM SPSS Statistics 22 (IBM Chicago, IL, USA) where P<0.05 
was deemed statistically significant. A test of normality was conducted to determine the 
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distribution for each variable with the independent student’s t-test then used for those 
variables of a normal distribution and the Mann-Whitney test used for those not of a normal 
distribution. Independent associations between the three anthropometric indices (BMI-z, WC-
z, and WHtR) and cardiometabolic risk were examined using separate multivariate logistic 
regression analysis models. The presence or absence of at risk levels of the three 
anthropometric indices (yes/no) was used as the dependant variable with the calculated odds 
ratios (OR) presented with their 95% confidence intervals (CI’s). Receiver operating 
characteristic (ROC) curve analyses were performed to demonstrate the discriminatory ability 
of the standardized anthropometric indices for predicting cardiometabolic risk quantified by 
the area under the curve (AUC). At each value the sensitivity (true-positive rate) and 
specificity (true-negative rate) for predicting cardiometabolic risk was calculated. The most 
sensitive cut-off value for the detection of adverse cardiometabolic risk was obtained from 
the Youden index, based on the value that maximized the sum of the sensitivity and 
specificity, with greater accuracy reflected in a higher score. ROC AUC values of ≥0.90 were 
considered excellent, 0.80–0.89 good, 0.70–0.79 fair, and <0.70 poor (Metz, 1978). 
Results 
As shown in Table 1, the overweight/obese group demonstrated significantly higher age and 
sex adjusted mean levels for BMI, WC, WHtR, systolic and diastolic blood pressure, 
triglycerides and cardiometabolic risk as well as lower HDL-c levels. The results from the 
multivariate logistic regression analysis are presented in Table 2. Individuals with an 
increased BMI were 2.16 (95% CI 1.03, 4.53, P = 0.039) times more likely to have elevated 
triglycerides, 2.90 (95% CI 1.09, 7.71, P = 0.027) times more likely to have reduced HDL-c 
levels, 2.48 (95% CI 1.22, 5.01, P = 0.010) times more likely to have elevated diastolic blood 
pressure, 1.91 (95% CI 1.01, 3.61, P = 0.046) times more likely to have ≥2 individual risk 
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factors and 2.59 (95% CI 1.42, 4.73, P = 0.002) times more likely to have increased 
cardiometabolic risk.  
 
Participants with an increased WC were 2.84 (95% CI 0.98, 8.26, P = 0.047) times more 
likely to have reduced HDL-c levels, 1.73 (95% CI 1.01, 2.95, P = 0.045) times more likely 
to have elevated systolic blood pressure, 3.06 (95% CI 1.47, 6.38, P = 0.002) times more 
likely to have elevated diastolic blood pressure, 1.92 (95% CI 1.10, 3.35, P = 0.021) times 
more likely to have ≥1 individual risk factors, 2.76 (95% CI 1.47, 5.16, P = 0.001) times 
more likely to have ≥2 individual risk factors and 2.34 (95% CI 1.35, 4.06, P = 0.002) times 
more likely to have increased cardiometabolic risk. Participants with an elevated WHtR were 
3.46 (95% CI 1.56, 7.67, P = 0.001) times more likely to have elevated triglycerides, 4.44 
(95% CI 1.62, 12.13, P = 0.002) times more likely to have reduced HDL-c levels, 2.33 (95% 
CI 1.06, 5.12, P = 0.032) times more likely to have elevated diastolic blood pressure, 1.99 
(0.96, 4.12, P = 0.016) times more likely to have ≥2 individual risk factors and 3.51 (95% CI 
1.71, 7.23, P = <0.001) times more likely to have increased cardiometabolic risk.  
 
The AUC values for the prediction of cardiometabolic risk are presented in Table 3. For all 
outcomes, BMI-z, WC-z and WHtR performed poorly in distinguishing pre-adolescents at 
elevated health risk with AUC’s ranging from 0.57 - 0.65. When examining the co-
occurrence of risk once participants had been stratified by BMI, the performance of both WC 
and WHtR improved.  The optimal WC-z cut-point value for identifying co-occurrence of 
risk ranged from 1.78 - 1.94, which corresponded to the 96th percentile, and correctly 
identified 68.2% of individuals with ≥ 1 and ≥ 2 individual risk factors (sensitivity) and 
68.1% and 61.3% of individuals without ≥ 1 and ≥ 2 individual risk factors (specificity). The 
only measure for which WC-z had good discriminatory ability (AUC = 0.81) was for 
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cardiometabolic risk with 74.3% of individuals accurately identified as being at risk and 
67.9% not at cardiometabolic risk.  
 
The optimal WHtR cut-point value for identifying co-occurrence of risk ranged from 0.47 - 
0.51. A cut-point value of 0.47 correctly identified 65.9% of individuals with ≥ 1 individual 
risk factors (sensitivity) and 61.2% of individuals without ≥ 1 individual risk factors 
(specificity) whereas the optimal WHtR cut-point value of 0.51 correctly identified 64.2% of 
individuals with ≥ 2 individual risk factors and 62.7% of individuals without ≥ 2 individual 
risk factors. Finally, the optimal WHtR cut-point value of 0.50 correctly identified 71.4% as 
being at risk and 70.4% not at cardiometabolic risk.   
 
Discussion 
This study examined the predictive utility of BMI-z, WC-z and WHtR using age and sex 
specific UK national reference values to predict the clustering of cardiometabolic risk in a 
non-representative sample of Scottish pre-adolescents. Findings from this cross-sectional 
study suggest that the UK age and sex specific national reference values used to define 
overweight and obesity performed well in identifying those with elevated cardiometabolic 
risk profiles. Our observations are unique since to the best of our knowledge, no study has 
compared the predictive abilities of BMI-z, WC-z and WHtR for the assessment of 
cardiometabolic risk using UK population specific growth standards in a pre-adolescent 
population comprised of children as young as 6 years of age.  
 
In agreement with the findings of recent studies (Graves et al., 2014, Kahn et al., 2014, 
Sardinha et al., 2016), our results suggest that BMI-z, WC-z and WHtR have broadly similar 
predictive abilities for identifying adverse levels of risk factors in overweight/obese youth. 
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Importantly, all three indicators were able to identify those individuals who exhibited a 
clustering of ≥2 or more cardiometabolic risk factors. Moreover, our observations also 
suggest that being overweight/obese, regardless of the indicator, was associated with a more 
than twofold increased odds for having clustered cardiometabolic risk when compared to 
individuals of a normal weight. Previous studies have shown that BMI, WC and WHtR have 
similar abilities in identifying youth with clustering of cardiometabolic risk (Adegboye et al., 
2010, Freedman et al., 2007, Khoury et al., 2013). Our findings extend these observations in a 
younger pre-adolescent cohort from the UK. Knowledge that the use of UK population 
specific reference data is able to distinguish those who present with a clustering of 
cardiometabolic risk factors is clinically useful and provides insight into the utility of these 
anthropometric thresholds.  
 
Findings from the ROC analysis suggested that the diagnostic accuracy of each indicator to 
identify individuals with clustered cardiometabolic risk, measured by the AUC, was 
significantly higher than what would be expected by chance (AUC > 0.5). Yet despite similar 
abilities, it was evident that the accuracy of all three indicators was poor even if the AUC 
values observed in this study are comparable to those noted elsewhere (Sardinha et al., 2016, 
Morandi et al., 2014). Moreover, the sensitivity of the models was low suggesting, like others 
(Sardinha et al., 2016), that these anthropometric measures are unable to correctly classify 
individuals with increased cardiometabolic risk. It should be noted nonetheless that there is 
not one measure of efficient standards, and thresholds can be selected depending upon the 
desired result. In this study the most sensitive cut-off value was determined based on the 
value that maximized the sum of both the sensitivity and specificity as have others (Sardinha 
et al., 2016).  
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The ROC generated cut-off values for WC-z produced values ranging from the 83 – 87th 
percentile which is close to the 85th percentile currently recommended to identify individuals 
as overweight (McCarthy et al., 2001). Despite increasing trends in waist circumference 
values, it is encouraging that these age and sex specific UK national reference values are able 
to distinguish individuals who may be susceptible to cardiometabolic risk. The ROC 
generated cut-off values for WHtR are broadly similar to those presented in a recent study 
involving UK children and adolescents (Graves et al., 2014) where the statistically optimum 
cut-point for the clustering of cardiometabolic risk factors ranged between 0.44 – 0.48.  
WHtR cut-points below 0.5 have also been suggested for the clustering of cardiometabolic 
risk in a large cohort of European and North American youth (Sardinha et al., 2016).The 
optimal ROC generated cut-off value for BMI-z to identify individuals with clustering of 
cardiometabolic risk ranged between the 58th and 65th percentile which may suggest that the 
criteria used to classify overweight status may underestimate risk in individuals whose weight 
is classified as normal. This finding is not unique as others have demonstrated similar 
findings in North American cohorts (Kakinami et al., 2012) where optimal BMI percentiles 
for detecting cardiometabolic risk covered a wide range of values depending upon the 
indicator of interest.  
 
When combining anthropometric indices to explore the combined effect of BMI-z with both 
WC-z and WHtR, an added benefit in the assessment of cardiometabolic risk was noted. Our 
observations from the UK are in accordance with the literature which recognizes the 
existence of metabolically benign obesity phenotypes as well as metabolically obese, normal-
weight phenotypes (Ruderman et al., 1998). Since waist measures are an effective indicator 
of visceral adiposity and is often cited as a key mediator of cardiometabolic dysfunction 
given its association with cardiometabolic risk and mortality (de Koning et al., 2007, Alberti 
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et al., 2009), our findings suggest that measures of visceral adiposity may predict health risks 
beyond that identified by BMI alone. This is an important observation given the dearth of 
evidence which has examined the predictive utility of BMI-z, WC-z and WHtR for 
identifying individuals with cardiometabolic risk from the UK, particularly when 
geographical location may be important when understanding the prevalence of 
cardiometabolic risk in youth (Sardinha et al., 2016).  
 
Despite our promising findings, limitations should be considered. Firstly, this cross-sectional 
design does not allow us to confer causality. Secondly, the lack of objectively measured 
physical activity and dietary habits, which are well-established confounders of a number of 
indicators measured, are acknowledged. Furthermore, since adiposity distribution and 
metabolic markers of cardiometabolic disease are influenced by pubertal status, future work 
should ensure that maturation status is controlled for in future analysis. Finally, our sample 
was small and drawn from one area of Scotland which limits the generalizability of our 
findings. Yet, to the best of our knowledge, only one previous study (Graves et al., 2014) has 
examined the predictive abilities of all three anthropometrical indices with cardiometabolic 
risk using UK recommended thresholds whilst no other study has involved Scottish pre-
adolescents. Since previous studies have tended to focus on North American cohorts, our 
findings add to the paucity of evidence examining the predictive utility of anthropometric 
indices for detecting cardiometabolic risk in children living in different cultural and 
geographical settings.  
 
In summary we believe that the findings of this study make an important contribution to the 
literature. We have demonstrated that the current definition of BMI for overweight in the UK 
has a similar discriminatory ability to that of WC-z and WHtR for identifying individuals at 
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cardiometabolic risk. Moreover, combining BMI-z with waist measures appear to further 
specify the cardiometabolic risk assessment of overweight/obese pre-adolescents. Further 
work is needed to establish the extent to which the combinations of these anthropometrical 
measures are able to identify future cardiometabolic risk.  
 
Conflicts of Interest: The authors have no conflicts of interest relevant to this article to 
disclose.
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Table 1 – Descriptive characteristics of participants by weight status. 
Values presented as mean ± (SD). BMI = Body mass index; HDL-c = high-density 
lipoprotein cholesterol; BP = Blood Pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable Normal Weight 
N = 162  
(72.4%) 
Overweight/obese 
N = 61 
 (27.6%) 
P value 
Age (years) 8.38 ± 2.35 9.07 ± 2.45 0.568 
BMI (kg/m2) 16.19 ± 1.48  21.87 ± 3.59   <0.001 
BMI-z -0.12 ± 0.72  1.93 ± 0.77  <0.001 
Waist-to-height ratio 0.44 ± 0.04  0.51 ± 0.06  <0.001 
Waist Circumference (cm) 58.02 ± 4.96  69.81 ± 10.26  <0.001 
Waist Circumference z score 0.55 ± 0.98 2.04 ± 0.95 <0.001 
Systolic BP z score 1.31 ± 1.22  1.44 ± 1.14  0.005 
Systolic BP (mmHg) 109 ± 12 114 ± 13 0.015 
Diastolic BP z score 0.16 ± 1.16  0.54 ± 1.33  <0.001 
Diastolic BP (mmHg) 67 ± 11 69 ± 10 0.353 
Glucose  z score -0.08 ± 1.02  0.10 ± 0.86  0.857 
Glucose (mmol/L) 4.83 ± 0.58  4.93 ± 0.49 0.182 
Triglycerides z score -0.09 ± 0.90  0.23 ± 1.17  0.025 
Triglycerides (mmol/L) 0.75 ± 0.32 0.87 ± 0.42 0.032 
HDL-c z score 0.10 ± 0.99  -0.30 ± 0.99  0.007 
HDL-c (mmol/L) 1.50 ± 0.37 1.35 ± 0.37 0.008 
Cardiometabolic risk z score 0.26 ± 2.05  1.51 ± 2.54  <0.001 
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Table 2. Multivariate-adjusted OR (95% CI) for cardiometabolic risk indicators across 3 anthropometric indices 
 Body Mass Index-z Waist Circumference-z Waist-to-Height Ratio 
 OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value 
Hypertriglyceridemia 2.16 (1.03, 4.53) 0.039 1.99 (0.95, 4.17) 0.064 3.46 (1.56, 7.67) 0.001 
Low HDL-c 2.90 (1.09, 7.71) 0.027 2.84 (0.98, 8.26) 0.047 4.44 (1.62, 12.13) 0.002 
Impaired fasting Glucose 0.86 (0.35, 2.13) 0.742 1.98 (0.87, 4.50) 0.100 0.52 (0.15, 1.83) 0.303 
Elevated systolic BP 
Elevated diastolic BP 
1.26 (0.70, 2.28) 
2.48 (1.22, 5.01) 
0.440 
0.010 
1.73 (1.01, 2.95) 
3.06 (1.47, 6.38) 
0.045 
0.002 
1.20 (0.60, 2.40) 
2.33 (1.06, 5.12) 
0.607 
0.032 
>1 Risk Factors 1.69 (0.89, 3.21) 0.107 1.92 (1.10, 3.35) 0.021 1.82 (0.84, 3.97) 0.127 
>2 Risk Factors 1.91 (1.01, 3.61) 0.046 2.76 (1.47, 5.16) 0.001 1.99 (0.96, 4.12) 0.016 
Cardiometabolic risk  2.59 (1.42, 4.73) 0.002 2.34 (1.35, 4.06) 0.002 3.51 (1.71, 7.23) <0.001 
HDL-c = high-density lipoprotein cholesterol; BP = Blood Pressure.  
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Table 3. AUC (95% CI) for anthropometric indices and cardiometabolic risk. 
Abbreviations: BMI, body mass index; AUC, area under the curve.  
 
 
 
 
  ≥ 1 Risk 
Factors 
≥ 2 Risk 
Factors 
Cardiometabolic risk BMI-z + ≥ 1 
Risk Factors 
BMI-z + ≥ 2 
Risk Factors 
BMI-z + 
Cardiometabolic 
risk 
Body Mass Index-z AUC 
95% CI 
P Value 
Sensitivity (%) 
Specificity (%) 
Cut-off (z-score / %) 
0.57 
0.50, 0.65 
0.073 
55.3 
51.4 
0.21/ 58 
0.59 
0.49, 0.6 
0.054 
56.7 
54.3 
0.38 / 65 
0.62 
0.54, 0.70 
0.002 
56.3 
44.1 
0.67 / 75 
   
Waist 
Circumference-z 
AUC 
95% CI 
P Value 
Sensitivity (%) 
Specificity (%) 
Cut-off (z-score / %) 
0.63 
0.57, 0.71 
<0.001 
62.3 
58.1 
0.97/ 83 
0.63 
0.55, 0.73 
<0.001 
68.2 
55.7 
1.01 / 84 
0.65 
0.56, 0.73 
<0.001 
59.8 
39.7 
1.12 / 87 
0.71 
0.58, 0.83 
0.010 
68.2 
68.1 
1.78 / 96 
0.73 
0.61, 0.86 
0.002 
68.2 
61.3 
1.94/ 98 
0.81 
0.70, 0.91 
<0.001 
74.3 
67.9 
1.82/ 96 
Waist-to-Height 
Ratio 
AUC 
95% CI 
P Value 
Sensitivity (%) 
Specificity (%) 
Cut-off  
0.58 
0.51, 0.66 
0.043 
65.1 
50.4 
0.44 
0.58 
0.49, 0.67 
0.047 
64.4 
58.4 
0.45 
0.60 
0.53, 0.68 
0.009 
56.3 
44.1 
0.46 
0.70 
0.56,0.83 
0.013 
65.9 
61.2 
0.47 
0.72 
0.84, 0.83 
0.020 
64.2 
62.7 
0.51 
0.75 
0.62, 0.87 
<0.001 
71.4 
70.2 
0.50 
